Waterdrop (NYSE:WDH - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research note issued on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings cut Waterdrop from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, October 2nd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Waterdrop currently has an average rating of "Sell".
View Our Latest Research Report on Waterdrop
Waterdrop Stock Performance
Shares of NYSE WDH opened at $1.00 on Friday. The company's fifty day moving average price is $1.02 and its 200 day moving average price is $1.38. Waterdrop has a 1 year low of $0.96 and a 1 year high of $2.03. The company has a market capitalization of $362.69 million, a PE ratio of 4.79 and a beta of -0.24.
Waterdrop (NYSE:WDH - Get Free Report) last released its quarterly earnings results on Tuesday, September 8th. The company reported $0.05 EPS for the quarter. Waterdrop had a net margin of 10.69% and a return on equity of 10.47%. The company had revenue of $213.16 million for the quarter.
Hedge Funds Weigh In On Waterdrop
An institutional investor recently bought a new stake in Waterdrop stock. Renaissance Technologies LLC purchased a new position in shares of Waterdrop Inc. Unsponsored ADR (NYSE:WDH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 57,957 shares of the company's stock, valued at approximately $94,000. Institutional investors and hedge funds own 1.96% of the company's stock.
About Waterdrop
(
Get Free Report)
Waterdrop Inc is a technology platform focused on insurance services and healthcare support in China. Through its online insurance marketplace, the company helps consumers compare and purchase insurance products, while providing insurers with digital distribution and customer-engagement services.
The company also operates Waterdrop Crowdfunding, an online medical expense fundraising platform intended to help individuals and families seek financial assistance for treatment-related costs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waterdrop, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waterdrop wasn't on the list.
While Waterdrop currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.